A novel and simplified method of culture of human blood-derived early endothelial progenitor cells for the treatment of ischemic vascular disease

Cell Transplantation

Volumn 20, Issue 9, 2011, Pages 1431-1443

  Bouchentouf, M ^a   Forner, K ^a   Cuerquis, J ^a   Boulassel, M R ^b   Routy, J P ^b   Waller, E K ^c   Quyyumi, A A ^c   Paradis, P ^a   Schiffrin, E L ^a,d   Galipeau, J ^a,c  

^a MCGILL UNIVERSITY   (Canada)

^b ROYAL VICTORIA HOSPITAL   (Canada)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

Endothelial progenitor cells (EPCs) growth factors culture method angiogenesis myocardial infarction (MI)

Indexed keywords

EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; FIBRONECTIN; SCATTER FACTOR; SOMATOMEDIN C; STEM CELL FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE FIBROSIS; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN SECRETION; SCID MOUSE; SERUM; STEM CELL TRANSPLANTATION;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; APOPTOSIS; BLOOD CELLS; CELL ADHESION; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELLS, CULTURED; ENDOTHELIAL CELLS; FIBRONECTINS; HEART FUNCTION TESTS; HUMANS; INFLAMMATION MEDIATORS; INJECTIONS, INTRAVENOUS; INSULIN-LIKE GROWTH FACTOR I; ISCHEMIA; MICE; MICE, INBRED NOD; MICE, SCID; MYOCARDIAL INFARCTION; STEM CELL TRANSPLANTATION; VASCULAR DISEASES;

MUS;

EID: 80855140448     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368910X557164     Document Type: Article

References (39)

1. Aries A. Paradis P. Lefebvre C. Schwartz R. J. Nemer M. Essential role of GATA-4 in cell survival and drug-induced cardiotoxicity. Proc. Natl. Acad. Sci. USA 101(18):6975-6980 2004.
2. Asahara T. Masuda H. Takahashi T. Kalka C. Pastore C. Silver M. Kearne M. Magner M. Isner J. M. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ. Res. 85(3):221-228 1999.
3. Asahara T. Murohara T. Sullivan A. Silver M. van der Zee R. Li T. Witzenbichler B. Schatteman G. Isner J. M. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275(5302):964-967 1997.
4. Assmus B. Schachinger V. Teupe C. Britten M. Lehmann R. Dobert N. Grunwald F. Aicher A. Urbich C. Martin H. Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation 106(24):3009-3017 2002.
5. Bouchentouf M. Paradis P. Forner K. A. Cuerquis J. Boivin M. N. Zheng J. Boulassel M. R. Routy J. P. Schiffrin E. L. Galipeau J. Monocyte derivatives promote angiogenesis and myocyte survival in a model of myocardial infarction. Cell Transplant. 19(4):369-386 2010.
6. Carmeliet P. Luttun A. The emerging role of the bone marrow-derived stem cells in (therapeutic) angiogenesis. Thromb. Haemost. 86(1):289-297 2001.
7. Eckle T. Grenz A. Kohler D. Redel A. Falk M. Rolauffs B. Osswald H. Kehl F. Eltzschig H. K. Systematic evaluation of a novel model for cardiac ischemic preconditioning in mice. Am. J. Physiol. Heart Circ. Physiol. 291(5):H2533-2540 2006.
8. Fuchs S. Baffour R. Zhou Y. F. Shou M. Pierre A. Tio F.O. Weissman N. J. Leon M. B. Epstein S. E. Kornowski R. Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. J. Am. Coll. Cardiol. 37(6):1726-1732 2001.
9. Gulati R. Jevremovic D. Peterson T. E, Chatterjee S, Shah V, Vile R. G, Simari R. D, Diverse origin and function of cells with endothelial phenotype obtained from adult human blood. Circ. Res. 93(11):1023-1025 2003.
10. Guyre C.A., Fisher J. L., Waugh M. G., Wallace P. K., Tretter C. G., Ernstoff M. S., Barth, Jr. R. J., Advantages of hydrophobic culture bags over flasks for the generation of monocyte-derived dendritic cells for clinical applications. J. Immunol. Methods 262(1-2):85-94 2002.
11. Hossne, Jr. N. A., Invitti A. L., Buffolo E., Azevedo S., Rodrigues de Oliveira J. S., Stolf N. G., Cruz L. E., Sanberg P. R., Refractory angina cell therapy (ReACT) involving autologous bone marrow cells in patients without left ventricular dysfunction: A possible role for monocytes. Cell Transplant. 18(12):1299-1310 2009.
12. Hur J., Yoon C. H., Kim H. S., Choi J. H., Kang H. J., Hwang K. K., Oh B. H., Lee M. M., Park Y. B., Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler. Thromb. Vasc. Biol. 24(2):288-293 2004.
13. Iglarz M. Touyz R. M. Viel E. C. Paradis P. Amiri F. Diep Q. N. Schiffrin E. L. Peroxisome proliferator-activated receptor-alpha and receptor-gamma activators prevent cardiac fibrosis in mineralocorticoid-dependent hypertension. Hypertension 42(4):737-743 2003.
14. Kalka C. Masuda H. Takahashi T. Kalka-Moll W. M. Silver M. Kearney M. Li T. Isner J. M. Asahara T. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc. Natl. Acad. Sci. USA 97(7):3422-3427 2000.
15. Kawamoto A. Tkebuchava T. Yamaguchi J. Nishimura H. Yoon Y. S. Milliken C. Uchida S. Masuo O. Iwaguro H. Ma H. Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation 107(3):461-468 2003.
16. Kocher A. A., Schuster M. D., Szabolcs M. J., Takuma S., Burkhoff D., Wang J., Homma S., Edwards N. M., Itescu S., Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat. Med. 7(4):430-436 2001.
17. Krenning G. van der Strate B. W. Schipper M. van Seijen X. J. Fernandes B. C. van Luyn M. J. Harmsen M. C. CD34+ cells augment endothelial cell differentiation of CD14+ endothelial progenitor cells in vitro. J. Cell. Mol. Med. 13(8B):2521-2533 2009.
18. Lara-Hernandez R., Lozano-Vilardell P., Blanes P., Torreguitart-Mirada N., Galmes A., Besalduch J., Safety and efficacy of therapeutic angiogenesis as a novel treatment in patients with critical limb ischemia. Ann. Vasc. Surg. 24(2):287-294 2010.
19. Leone A. M., Rutella S., Bonanno G., Abbate A., Rebuzzi A. G., Giovannini S., Lombardi M., Galiuto L., Liuzzo G., Andreotti F., Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function. Eur. Heart J. 26(12):1196-1204 2005.
20. Lesimple T., Moisan A., Toujas L., Autologous human macrophages and anti-tumour cell therapy. Res. Immunol. 149(7-8):663-671 1998.
21. Lin Y., Weisdorf D. J., Solovey A., Hebbel R. P., Origins of circulating endothelial cells and endothelial outgrowth from blood. J. Clin. Invest. 105(1):71-77 2000.
22. Metzler B. Hammerer-Lercher A. Jehle J. Dietrich H. Pachinger O. Xu Q. Mair J. Plasma cardiac troponin T closely correlates with infarct size in a mouse model of acute myocardial infarction. Clin. Chim. Acta 325(1-2):87-90 2002.
23. Meyer G. P. Wollert K. C. Lotz J. Steffens J. Lippolt P. Fichtner S. Hecker H. Schaefer A. Arseniev L. Hertenstein B. Intracoronary bone marrow cell transfer after myocardial infarction: Eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation 113(10):1287-1294 2006.
24. Murohara T. Ikeda H. Duan J. Shintani S. Sasaki K. Eguchi H. Onitsuka I. Matsui K. Imaizumi T. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J. Clin. Invest. 105(11):1527-1536 2000.
25. Peichev M. Naiyer A. J. Pereira D. Zhu Z. Lane W. J. Williams M. Oz M. C. Hicklin D. J. Witte L. Moore M. A. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 95(3):952-958 2000.
26. Rehman J. Li J. Orschell C. M. March K. L. Peripheral blood endothelial progenitor cells are derived from monocyte macrophages and secrete angiogenic growth factors. Circulation 107(8):1164-1169 2003.
27. Reyes M. Dudek A. Jahagirdar B. Koodie L. Marker P. H. Verfaillie C. M. Origin of endothelial progenitors in human postnatal bone marrow. J. Clin. Invest. 109(3):337-346 2002.
28. Sanberg P. R., Park D. H., Kuzmin-Nichols N., Cruz E., Hossne, Jr. N. A., Buffolo E., Willing A. E., Monocyte transplantation for neural and cardiovascular ischemia repair. J. Cell. Mol. Med. 14(3):553-563 2010.
29. Schachinger V., Assmus B., Britten M. B., Honold J., Lehmann R., Teupe C., Abolmaali N. D., Vogl T. J., Hofmann W. K., Martin H., Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: Final one-year results of the TOPCARE-AMI Trial. J. Am. Coll. Cardiol. 44(8):1690-1699 2004.
30. Senegaglia A. C. Barboza L. A. Dallagiovanna B. Aita C. A. Hansen P. Rebelatto C. L. Aguiar A. M. Miyague N. I. Shigunov P. Barchiki F. Are purified or expanded cord blood-derived CD133+ cells better at improving cardiac function? Exp. Biol. Med. (Maywood) 235(1):119-129 2010.
31. Stamm C. Westphal B. Kleine H. D. Petzsch M. Kittner C. Klinge H. Schumichen C. Nienaber C. A. Freund M. Steinhoff G. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 361(9351):45-46 2003.
32. Takahashi T. Kalka C. Masuda H. Chen D. Silver M. Kearney M. Magner M. Isner J. M. Asahara T. Ischemia-and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat. Med. 5(4):434-438 1999.
33. Tatsumi T. Ashihara E. Yasui T. Matsunaga S. Kido A. Sasada Y. Nishikawa S. Hadase M. Koide M. Nakamura R. Intracoronary transplantation of non-expanded peripheral blood-derived mononuclear cells promotes improvement of cardiac function in patients with acute myocardial infarction. Circ. J. 71(8):1199-1207 2007.
34. Tatsumi T., Matsubara H. Therapeutic angiogenesis for peripheral arterial disease and ischemic heart disease by autologous bone marrow cells implantation. Nippon Rinsho 64(11):2126-2134 2006.
35. Urbich C. Heeschen C. Aicher A. Dernbach E. Zeiher A. M. Dimmeler S. Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells. Circulation 108(20):2511-2516 2003.
36. van der Meer J. W., van de Gevel J. S., Kramps J. A., van Zwet T. L., Leijh P. C., van Furth R., Characteristics of human monocytes cultured in the Teflon culture bag. Immunology 47(4):617-625 1982.
37. Xin Z., Meng W., Ya-Ping H., Wei Z., Different biological properties of circulating and bone marrow endothelial progenitor cells in acute myocardial infarction rats. Thorac. Cardiovasc. Surg. 56(8):441-448 2008.
38. Yeh E. T., Zhang S., Wu H. D., Korbling M., Willerson J. T., Estrov Z., Transdifferentiation of human peripheral blood CD34+-enriched cell population into cardiomyocytes, endothelial cells, and smooth muscle cells in vivo. Circulation 108(17):2070-2073 2003.
39. Yoon C. H., Hur J., Park K. W., Kim J. H., Lee C. S., Oh I. Y., Kim T. Y., Cho H. J., Kang H. J., Chae I. H., Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: The role of angiogenic cytokines and matrix metalloproteinases. Circulation 112(11):1618-1627 2005.